Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine doses.
Matsuura T, Fukushima W, Nakagama Y, Kido Y, Kase T, Kondo K, Kaku N, Matsumoto K, Suita A, Mukai E, Nitahara Y, Konishi A, Kasamatsu A, Nakagama S, Nakagami-Yamaguchi E, Ohfuji S, Kaneko Y, Kaneko A, Kakeya H, Hirota Y. Matsuura T, et al. Among authors: nakagama s. Sci Rep. 2024 Mar 27;14(1):7217. doi: 10.1038/s41598-024-57931-0. Sci Rep. 2024. PMID: 38538722 Free PMC article.
Differential cardiomyocyte transcriptomic remodeling during in vitro Trypanosoma cruzi infection using laboratory strains provides implications on pathogenic host responses.
Candray-Medina KS, Nakagama Y, Ito M, Nakagama S, Tshibangu-Kabamba E, Takeda N, Sugiura Y, Nitahara Y, Michimuko-Nagahara Y, Kaku N, Onizuka Y, Arias CE, Mejia M, Alas K, Peña S, Maejima Y, Komuro I, Nakajima-Shimada J, Kido Y. Candray-Medina KS, et al. Among authors: nakagama s. Trop Med Health. 2023 Dec 7;51(1):68. doi: 10.1186/s41182-023-00552-6. Trop Med Health. 2023. PMID: 38062533 Free PMC article.
Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response.
Nakagama S, Nakagama Y, Komase Y, Kudo M, Imai T, Tshibangu-Kabamba E, Nitahara Y, Kaku N, Kido Y. Nakagama S, et al. Front Immunol. 2023 Jan 19;14:1087473. doi: 10.3389/fimmu.2023.1087473. eCollection 2023. Front Immunol. 2023. PMID: 36742291 Free PMC article.
Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity.
Nakagama Y, Candray K, Kaku N, Komase Y, Rodriguez-Funes MV, Dominguez R, Tsuchida T, Kunishima H, Nagai E, Adachi E, Ngoyi DM, Yamasue M, Komiya K, Hiramatsu K, Uemura N, Sugiura Y, Yasugi M, Yamagishi Y, Mikamo H, Shiraishi S, Izumo T, Nakagama S, Watanabe C, Nitahara Y, Tshibangu-Kabamba E, Kakeya H, Kido Y. Nakagama Y, et al. Among authors: nakagama s. J Infect Dis. 2023 Mar 28;227(6):780-787. doi: 10.1093/infdis/jiac492. J Infect Dis. 2023. PMID: 36546706 Free PMC article.
25 results